Immediate Impact

1 from Science/Nature 67 standout
Sub-graph 1 of 23

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
4 intermediate papers

Works of Simon Meller being referenced

Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma
2016
Whole-Body Dosimetry for Individualized Treatment Planning of 131I-MIBG Radionuclide Therapy for Neuroblastoma
2009
and 1 more

Author Peers

Author Last Decade Papers Cites
Simon Meller 200 75 96 111 99 14 486
C Parmentier 48 144 38 41 132 23 427
Hélène Lanic 64 14 40 37 107 15 437
Mason Bond 97 56 123 56 13 15 502
Elena Pérez‐Ceballos 60 27 61 47 29 25 563
Rachele Amodeo 29 61 77 74 23 16 483
B.G. Taal 138 164 34 245 16 20 534
Moshe Friedman 61 175 48 53 32 18 511
Andrew McQuillan 23 86 90 122 41 19 548
J. Moschandrea 25 86 78 226 54 13 535
Kyung Cho 101 131 85 192 27 18 559

All Works

Loading papers...

Rankless by CCL
2026